No approval for Covaxin yet, WHO says ‘additional clarifications’ needed from Bharat Biotech

The World Health Organization (WHO) on Tuesday said “extra explanations” are required from Bharat Biotech in regards to its Covid-19 immunization ‘Covaxin’ for a last “hazard advantage evaluation” prior to suggesting the antibody for crisis use. “The Technical Advisory Group for Emergency Use Listing (TAG-EUL) is an autonomous warning gathering that gives proposals to WHO …